Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

NCT00003453 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment

Conditions

Stage IV Adrenocortical Carcinoma

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute